Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST
Globus Medical Revenue
Globus Medical had revenue of $763.72M in the quarter ending September 30, 2026, a decrease of -0.69%. This brings the company's total for the last twelve months to $3.14B, up 13.35% year-over-year. In the year 2025, Globus Medical had annual revenue of $2.94B with 16.65% growth. That makes Globus Medical the 3,707th largest company in the world by revenue and 1,030th in the United States.
Revenue (ttm)
$3.14B
Revenue Growth
+13.35%
P/S Ratio
2.82
Revenue / Employee
$523,268
Employees
6,000
Market Cap
8.86B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Globus Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.94B | 419.58M | 16.65% |
| Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
| Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
| Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
| Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
| Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
| Dec 31, 2019 | 785.37M | 72.40M | 10.15% |
| Dec 31, 2018 | 712.97M | 76.99M | 12.11% |
| Dec 31, 2017 | 635.98M | 71.98M | 12.76% |
| Dec 31, 2016 | 563.99M | 19.24M | 3.53% |
| Dec 31, 2015 | 544.75M | 70.38M | 14.84% |
| Dec 31, 2014 | 474.37M | 39.91M | 9.19% |
| Dec 31, 2013 | 434.46M | 48.47M | 12.56% |
| Dec 31, 2012 | 385.99M | 54.52M | 16.45% |
| Dec 31, 2011 | 331.48M | 43.28M | 15.02% |
| Dec 31, 2010 | 288.20M | 33.85M | 13.31% |
| Dec 31, 2009 | 254.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zimmer Biomet Holdings | 8.57B |
| Smith & Nephew | 6.30B |
| Bruker | 3.51B |
| Insulet | 3.19B |
| Bio-Rad Laboratories | 2.59B |
| Bio-Rad Laboratories | 2.59B |
| Penumbra | 1.56B |
| LivaNova | 1.51B |
GMED News
- 3 days ago - Globus Medical Transcript: Jefferies Global Healthcare Conference - Transcripts
- 12 days ago - Globus Medical to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 14 days ago - Globus Medical price target lowered to $100 from $106 at BofA - TheFly
- 15 days ago - Globus Medical price target lowered to $90 from $100 at Truist - TheFly
- 15 days ago - Globus Medical price target raised to $100 from $99 at Wells Fargo - TheFly
- 15 days ago - Globus Medical price target lowered to $105 from $115 at Canaccord - TheFly
- 15 days ago - Globus Medical downgraded to Market Perform from Outperform at BMO Capital - TheFly
- 16 days ago - Globus Medical Earnings Call Transcript: Q3 2026 - Transcripts